RXRXCAUTIOUS

RXRX Current Ratio Analysis

5.03x

Updated 878h ago·SEC filings & market data

Key Takeaway

The current ratio measures a company's ability to pay short-term debts with its short-term assets; at 5.03x, RXRX has $5.03 in current assets for every $1 of current liabilities.

Sector Performance

94th percentile

RXRX

5.03x

Sector Median

1.26x

Sector Avg

2.60x

Prior Period

5.47x(Aug 2026)

↓ Declining
📊

Deep Analysis

The current ratio measures a company's ability to pay short-term debts with its short-term assets; at 5.03x, RXRX has $5.03 in current assets for every $1 of current liabilities.

This is far above the sector median of 1.25x, placing the company in the 95th percentile among peers. The year-over-year change is not available, but the quarter-over-quarter change shows a decline of 8.0%, from 5.47x to 5.03x. The high level suggests very strong liquidity, yet the downward trend may indicate that cash or other current assets are being reduced or deployed. That combination—ample liquidity but a shrinking buffer—supports a cautious view, as excess current assets can also signal inefficient capital use. Thus, this metric aligns with the overall CAUTIOUS verdict rather than contradicting it.

Frequently Asked Questions

What does the Current Ratio tell investors about RXRX?

Measures short-term financial health. A ratio above 1.5 is generally healthy; below 1.0 may indicate liquidity stress.

How is the Current Ratio calculated?

Current Ratio is calculated as: Current Assets / Current Liabilities.

The Formula

Current Assets / Current Liabilities

Why It Matters

Measures short-term financial health. A ratio above 1.5 is generally healthy; below 1.0 may indicate liquidity stress.

Advertisement

Master RXRX's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full RXRX research report →

Free account — no credit card

RXRX

5.03x

Sector Median

1.26x

Sector Avg

2.60x

How RXRX's Current Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.